NT5E CpG island methylation is a favourable breast cancer biomarker. - Wikidata - wikimedia - TriplyDB

NT5E CpG island methylation is a favourable breast cancer biomarker.

NT5E CpG island methylation is a favourable breast cancer biomarker.

http://www.wikidata.org/entity/Q36075236

about

The roles of CD73 in cancer Clinical significance of methylation of E-cadherin and p14ARF gene promoters in skin squamous cell carcinoma tissues.Combining phenotypic and proteomic approaches to identify membrane targets in a 'triple negative' breast cancer cell type Genetic variation in the adenosine regulatory cycle is associated with posttraumatic epilepsy development Subpathway-GMir: identifying miRNA-mediated metabolic subpathways by integrating condition-specific genes, microRNAs, and pathway topologies CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer DNA methylation in ductal carcinoma in situ of the breast.CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer.Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum.Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancer.CD73-adenosine: a next-generation target in immuno-oncology.CD73s protection of epithelial integrity: Thinking beyond the barrier.Anti-CD73 therapy impairs tumor angiogenesis.

P2860

Q34003164-E2730916-CB77-4D65-9308-303A3E82F4FE Q34042261-1B24A166-B9AE-4FEF-985B-3EF483213343 Q34584880-CCBEFD08-CAB3-486C-809E-CA6EAEECBD5B Q35911926-354AC3B7-1A8F-4EA2-8DAD-FB98ED699933 Q36629543-619750E6-8313-41FF-96FA-BF503DE372D2 Q36991010-17A175A6-2FCC-45B3-BC03-FE85F7C1AC48 Q36998647-5DBE3A16-A0A2-4019-8E15-7344750BD1A5 Q37624627-FC4A93DF-53C9-4B9D-A2D1-6A8C16C2E7F0 Q37639092-0E65AB52-B279-492E-839E-2D4D8A94C6F1 Q38209586-97BAAA78-BD7D-4C14-9510-18F43C7E8CF1 Q38711094-068B5316-D60D-465D-9ACD-9E6DEB7DBF10 Q40783577-E6B71052-2EBD-4238-9B87-B7DD7CC9E932 Q45737780-24E5C669-CBA9-43FD-BDCB-20AEE5B56C35

P2860

NT5E CpG island methylation is a favourable breast cancer biomarker.

http://www.wikidata.org/entity/Q36075236

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

NT5E CpG island methylation is a favourable breast cancer biomarker.

@ast

NT5E CpG island methylation is a favourable breast cancer biomarker.

@en

type

label

NT5E CpG island methylation is a favourable breast cancer biomarker.

@ast

NT5E CpG island methylation is a favourable breast cancer biomarker.

@en

prefLabel

NT5E CpG island methylation is a favourable breast cancer biomarker.

@ast

NT5E CpG island methylation is a favourable breast cancer biomarker.

@en

P1433

Q36075236-96721F41-5C04-4CB4-996F-D7CCE62CD275

P1476

Q36075236-33F111FB-F6F2-463C-B5CA-34FE31BC4692

P2093

Q36075236-09324B82-1CE9-464A-AF55-92F87998C3C9

Q36075236-0E165742-13FA-4976-B393-61EE195452D1

Q36075236-0E7EA51F-FB2D-4FC9-8E5C-D8CF44D069C5

Q36075236-1975F4D5-42A1-459F-A5CC-B0220A068673

Q36075236-282D355B-A266-40D3-89F0-2B8F784E8FCB

Q36075236-2902D806-9F90-403A-97B8-75F378E82928

Q36075236-67B45D30-29E5-48BB-B882-E8B059EBC13A

Q36075236-78240E32-9C52-45E8-A5C5-274851A623DB

Q36075236-91B9AA3F-042F-413A-8C29-C604E0825263

Q36075236-98E2F60F-3F7E-4BB5-8248-79C08ED18CF5

P2860

Q36075236-16EBD51B-61C9-409B-AFEA-1B9F89388951

Q36075236-18424F73-2745-4CB1-886E-595689957A58

Q36075236-1A44977E-C85D-4570-BF16-ED522DE436C9

Q36075236-1B2BB578-FF54-4344-9A57-167C66C052C0

Q36075236-1FB83617-3200-4B18-A4C2-701B94506B55

Q36075236-20F9B4B5-3B05-46ED-B705-07E22BAE16A9

Q36075236-21563337-C0B2-450A-92C0-D386C5CDEED1

Q36075236-38605F8F-44D0-491A-8D18-5C2D9D79897C

Q36075236-5E4E48C9-1261-40A9-89CD-86C624B62802

Q36075236-5F399F6F-B3F3-4835-AEB8-8892CB8ED31C

P2888

Q36075236-1B63C317-D428-44F2-A538-68E9EBD8DEC1

P304

Q36075236-1EB4C4E5-29EE-4827-8383-816B69C52899

P31

Q36075236-9D1218CE-8982-4CCB-8473-15EC93AD1A79

P356

Q36075236-2F02712E-B330-47FC-AA18-9048320FF14A

P407

Q36075236-0E3B6BE2-46A5-4169-94E0-250E7E93603C

P433

Q36075236-E638DD43-0367-4499-BFF7-90AE9D023506

P478

Q36075236-F6AA39C7-9433-4844-A99D-6BAC0E7D1D55

P577

Q36075236-544141CB-B73F-4EC6-BD77-F159940F2DA1

P5875

Q36075236-3D1A1BFC-1389-41AF-A8A1-D4BB6B42375C

P698

Q36075236-9BF42993-C0CD-4107-96FA-BFFBA5AEB885

P921

Q36075236-2C262C54-91AA-41F9-846E-6553F59D24F7

P932

Q36075236-5679E542-A53D-48B7-B760-F463A9CD7153

P356

P1433

British Journal of Cancer

P1476

NT5E CpG island methylation is a favourable breast cancer biomarker.

@en

P2093

A Comino

http://www.w3.org/2001/XMLSchema#string

A McHugh

http://www.w3.org/2001/XMLSchema#string

A Thompson

http://www.w3.org/2001/XMLSchema#string

C Lo Nigro

http://www.w3.org/2001/XMLSchema#string

C Palmieri

http://www.w3.org/2001/XMLSchema#string

C Proby

http://www.w3.org/2001/XMLSchema#string

D Vivenza

http://www.w3.org/2001/XMLSchema#string

E Briasoulis

http://www.w3.org/2001/XMLSchema#string

E Hatzimichael

http://www.w3.org/2001/XMLSchema#string

H Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals

The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer

Molecular portraits of human breast tumours

Assignment of ecto-5'-nucleotidase to human chromosome 6

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

5'-Nucleotidase: molecular structure and functional aspects

5′-Nucleotidase: molecular structure and functional aspects

Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS).

Gene-expression signatures in breast cancer.

Breast cancer classification and prognosis based on gene expression profiles from a population-based study.

P2888

P304

75-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2012.212

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225087992

http://www.w3.org/2001/XMLSchema#string

P698

22653144

http://www.w3.org/2001/XMLSchema#string

P921

P932

3389412

http://www.w3.org/2001/XMLSchema#string